Sign in
4

Changes in Ownership

Guardant Health, Inc. Filed Acc 0001214130-25-000005

Director sold 26 shares at $55.63 ($1,446)

  • Director acquired 68 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

POTTER MYRTLE S · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-15 Exercise or conversion : show line 1 in the form 10b5-1 +68 18,307 D
2025-09-17 Sale : show line 2 in the form 10b5-1 −26 $55.63 $1,446 18,281 D
Open-market sales · 26 sh · avg $55.63 · $1,446

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-15 Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units −68 69 D
Loading xslF345X05/wk-form4_1758143824.xml…